Tag: Study

Posted on

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

Condition:   Asthma
Interventions:   Drug: Fluticasone furoate (FF) Dry Powder Inhaler;   Drug: Fluticasone propionate (FP) Dry Powder Inhaler;   Drug: Budesonide (BUD) Turbuhaler;   Drug: Placebo (ELLIPTA or DISKUS)
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified December 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Posted on

Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine

Condition:   Bronchial Asthma
Interventions:   Drug: Ke Chuan Liu Wei Mixture;   Drug: Chuan Xiong Ping Chuan Mixture;   Drug: Xie Wu Capsule;   Drug: Dan Ma Jia Tablet;   Drug: Zhi Chuan Capsule;   Drug: Bu Shen Na Qi Granule;   Drug: Ke Chuan Liu Wei Mixture placebo;   Drug: Chuan Xiong Ping Chuan Mixture placebo;   Drug: Xie Wu Capsule placebo;   Drug: Dan Ma Jia Tablet placebo;   Drug: Zhi Chuan Capsule placebo;   Drug: Bu Shen Na Qi Granule placebo
Sponsor:   Shanghai University of Traditional Chinese Medicine
Not yet recruiting – verified October 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Posted on

A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.

Condition:   Asthma, Chronic Obstructive Pulmonary Disease (COPD)
Interventions:   Drug: Treatment A – AZD7594;   Drug: Treatment B – AZD7594;   Drug: Treatment C – AZD7594
Sponsor:   AstraZeneca
Not yet recruiting – verified October 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days